Canadian Investment Regulatory Organization Trading Halt – SURF.A; SURF.U

The following issues have been halted by CIRO Company: Starlight U.S. Residential Fund TSX-Venture Symbol: SURF.A All Issues: Yes Reason: Pending Delisting Halt Time (ET): 8:01 AM Company: Starlight U.S. Residential Fund TSX-Venture Symbol: SURF.U All Issues: Yes Reason: Pending Delisting Halt Time (ET): 8:01 AM CIRO can make a decision to impose a temporary […]

Eastern International Ltd. Entered into Contract for its First Photovoltaic Power Generation Construction Project With a Total Contract Price of RMB 42.5 Million (approximately US$ 6.04 million)

Eastern International Ltd. (“Eastern International” or the “Company”) (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services including project logistic and general logistic for Company clients, today announced that its wholly-owned subsidiary, Guizhou Tianrun Zhicheng Construction Engineering Co., Ltd. (“Guizhou Tianrun”), has entered into a construction contract (the “Contract”) with Weifang Branch of

Mynd.ai Advances Platform Expansion and Ecosystem Monetization Strategy Through Planned Collaboration with Q101 Foundation

Mynd.ai, Inc. (“Mynd” or the Company) (NYSE American: MYND), a global leader in interactive classroom technology, today announced that through its subsidiary, Promethean, is working with the Q101 Foundation toward finalizing a strategic Memorandum of Understanding (“MOU”) that is expected to support Mynd's next phase of platform expansion, product diversification, and long-term ecosystem monetization. The

Canadian Investment Regulatory Organization Trade Resumption – IVQ.NT.U

Trading resumes in: Company: Invesque Inc. TSX Symbol: IVQ.NT.U All Issues: No Resumption (ET): 8:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees

Canadian Investment Regulatory Organization Trading Halt – SURF.UN

The following issues have been halted by CIRO Company: Starlight U.S. Residential Fund (Multi-F TSX-Venture Symbol: SURF.UN All Issues: Yes Reason: Pending Confirmation of Closing of the Arrangement Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts

Cone Health Announces New CEO

Dr. Paul Krakovitz will join the leading regional health system in 2026. Following a nationwide search, Dr. Paul Krakovitz, FACS, has been named the next chief executive officer at Cone Health. He will join the health system on March 16, 2026. https://mma.prnewswire.com/media/2851338/Cone_Health_CEO_Dr_Paul_Krakovitz.jpg Krakovitz is a transformational, mission-driven leader with more than two decades of experience

Canadian Investment Regulatory Organization Trading Halt – IVQ.NT.U

The following issues have been halted by CIRO: Company: Invesque Inc. TSX Symbol: IVQ.NT.U All Issues: No Reason: Pending News Halt Time (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly

Halper Sadeh LLC Encourages SOAR, HTBK, WBD, CVBF Shareholders to Contact the Firm to Discuss Their Rights

Shareholders should contact the firm as there may be limited time to enforce your rights. Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg Volato Group, Inc. (NYSE: SOAR)'smerger with M2i Global, Inc.

Foresee Pharmaceuticals announces the Casppian Phase 3 Study Meets Primary Efficacy Endpoint, Demonstrating Robust LH Suppression with 6-Month Dosing Interval of leuprolide mesylate

— The proportion of patients with serum luteinizing hormone (LH) suppression to < 4 mIU/mL at 60 minutes following a GnRHa stimulation test at Week 24 was 94%, and the results were statistically significant (P-value = 0.0005), which exceeded the pre-specified success criterion. — Leuprolide mesylate 42mg injection (FP-001) was well tolerated in patients with

Block & Leviton LLP and Pomerantz LLP Announce Certified Class Action on Behalf of Purchasers of Nikola Corporation securities – NKLAQ

Block & Leviton LLP and Pomerantz LLP announce that the United States District Court for the District of Arizona has approved the following announcement of a certified class action that would benefit purchasers of Nikola Corporation Securities (OTCMKTS: NKLAQ): UNITED STATES DISTRICT COURT DISTRICT OF ARIZONA Daniel Borteanu, Individually and on Behalf of No. CV-20-01797-PHX-SPLAll

Scroll to Top